- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01799681
The Effects of the Hopeful Outdoor Parkinson Exercise (HOPE) Program on Improving Balance Performance in Parkinsonian Non-fallers and Single Fallers
March 18, 2015 updated by: Margaret Kit Yi Mak, The Hong Kong Polytechnic University
The Effects of the Hopeful Outdoor Parkinson Exercise (HOPE) Program on Improving Balance, Gait and Functional Performance in Parkinsonian Non-fallers and Single Fallers - a Randomized Controlled Trial With 12-month Follow-up
To determine whether the 8-week Hopeful Outdoor Parkinson's Exercise (HOPE) Program would be effective in improving balance performance, physical functions, gait parameter, balance confidence, health-related quality-of-life, disease-specific motor performance and fall-related outcomes in Parkinson's disease (PD) non-fallers and single fallers.
Study Overview
Status
Completed
Conditions
Detailed Description
Previous studies demonstrated that multi-modal balance training program was effective in improving balance performance in people with PD.
However they did not include all the balance domains and outdoor fall-prone activities have been overlooked.
We designed a task- and context-specific balance training program based on the framework of the Balance Evaluation Systems Test (BESTest) to target all six balance domains including biomechanical constraints, stability limits and verticality, anticipatory postural adjustments, reactive postural responses, sensori-motor integration and dynamic gait control.
Study Type
Interventional
Enrollment (Actual)
84
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Hong Kong SAR, China
- The Hong Kong Polytechnic University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
30 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- diagnosed with PD by a neurologist (Fahn and Elton, 1987);
- aged 30 to 85 years;
- at modified Hoehn and Yahr (H&Y) stage 1.5 to 3 (Hoehn and Yahr ,1967; Goetz et al., 2004);
- able and willing to give written consent for participation in the study;
- living at home in the community;
- able to walk independently for 30 metres with or without an assistive device.
Exclusion Criteria:
- any neurological conditions other than PD;
- significant musculoskeletal or cardiopulmonary diseases;
- other disorders that may affect balance or locomotion;
- taken any structured behavioral or exercise programs in the past 3 months
- or they are receiving regular physical rehabilitation at present;
- unstable condition on anti-parkinsonian medications;
- surgical interventions for PD;
- communication or cognitive deficits with mini-mental state examination, (MMSE) <24/30 (Folstein et al., 1975);
- a history of more than two falls in the previous 12 months.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: EXPERIMENTAL
a 4-week indoor and 4-week outdoor balance training with stretching, strength and functional training, Balance Dance, Modified Wing Chun, Square stepping exercise, and fall-prone activities practice
|
stretching, strength and functional training, Balance Dance, Modified Wing Chun, Square stepping exercise, and fall-prone activities practice
|
Active Comparator: CONTROL
an eight-week training on upper limb stretching and strengthening, hand agility exercise, knot tying and Chinese calligraphy
|
upper limb stretching and strengthening, hand agility exercises, knot tying and Chinese calligraphy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Changes from baseline Balance Systems Evaluation Test total and subsection scores at post 4-week training, post 8-week training, 6- and 12-month follow-ups
Time Frame: 12 months after intervention
|
12 months after intervention
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Changes from baseline comfortable gait speed at post 4-week training, post 8-week training, 6- and 12-month follow-ups
Time Frame: 12 months after intervention
|
12 months after intervention
|
Changes from baseline dual task timed-up-and-go time at post 4-week training, post 8-week training, 6- and 12-month follow-ups
Time Frame: 12 months after intervention
|
12 months after intervention
|
Changes from baseline timed-up-and-go time at post 4-week training, post 8-week training, 6- and 12-month follow-ups
Time Frame: 12 months after intervention
|
12 months after intervention
|
Changes from baseline five-times-sit-to-stand time at post 4-week training, post 8-week training, 6- and 12-month follow-ups
Time Frame: 12 months after intervention
|
12 months after intervention
|
Changes from baseline one-leg stance time at post 4-week training, post 8-week training, 6- and 12-month follow-ups
Time Frame: 12 months after intervention
|
12 months after intervention
|
Changes from baseline Activities-specific Balance Confidence Scale at post 4-week training, post 8-week training, 6- and 12-month follow-ups
Time Frame: 12 months after intervention
|
12 months after intervention
|
Changes from baseline Parkinson's disease Questionnaire (PDQ-39) at post 4-week training, post 8-week training, 6- and 12-month follow-ups
Time Frame: 12 months after intervention
|
12 months after intervention
|
Other Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Changes from baseline Movement Disorder Society - Unified Parkinson's Disease Rating Scale (MDS-UPDRS) III at post 4-week training, post 8-week training, 6-and 12-month follow-ups
Time Frame: 12 months after intervention
|
12 months after intervention
|
Ratios of total and injurious non-fallers to fallers
Time Frame: 12 months after intervention
|
12 months after intervention
|
Total and Injurious fall rates
Time Frame: 12 months after intervention
|
12 months after intervention
|
The time to first fall and time to first injurious fall
Time Frame: 12 months after intervention
|
12 months after intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Margaret KY Mak, PhD, The Hong Kong Polytechnic University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2011
Primary Completion (Actual)
January 1, 2014
Study Completion (Actual)
December 1, 2014
Study Registration Dates
First Submitted
February 21, 2013
First Submitted That Met QC Criteria
February 24, 2013
First Posted (Estimate)
February 27, 2013
Study Record Updates
Last Update Posted (Estimate)
March 20, 2015
Last Update Submitted That Met QC Criteria
March 18, 2015
Last Verified
March 1, 2015
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- approvalletter_20110823001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson's Disease
-
Ohio State UniversityCompletedParkinson's Disease | Parkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease | Parkinson Disease, Idiopathic | Parkinson's Disease, IdiopathicUnited States
-
Assistance Publique - Hôpitaux de ParisFrance Parkinson AssociationUnknownHealthy Controls | Parkinson's Disease With LRRK2 Mutation | Parkinson's Disease Without LRRK2 MutationFrance
-
Merck Sharp & Dohme LLCCompletedParkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease
-
Universidade Federal de PernambucoCompletedParkinson's Disease.Brazil
-
University Hospital, GrenobleCompletedParkinson's Disease (Disorder)France
-
Neurocrine BiosciencesVoyager TherapeuticsCompletedBrain Diseases | Central Nervous System Diseases | Nervous System Diseases | Parkinson's Disease | Parkinsonian Disorders | Movement Disorders | Neurodegenerative Diseases | Idiopathic Parkinson's Disease | Basal Ganglia DiseaseUnited States
-
Second Affiliated Hospital of Soochow UniversityShanghai Regenelead Therapies Co., Ltd.RecruitingAdvanced Parkinson's DiseaseChina
-
AbbVieRecruitingParkinson's Disease (PD)Germany, Denmark, Spain
-
Beijing Tiantan HospitalRecruitingPD - Parkinson's DiseaseChina
-
Hubert FernandezRecruitingParkinson's Disease, IdiopathicUnited States
Clinical Trials on an 8-week blended indoor-outdoor exercise program
-
Hong Kong Baptist UniversityRecruitingDepressive SymptomsHong Kong
-
Baylor College of MedicineMayo ClinicActive, not recruitingChronic Kidney DiseaseUnited States
-
University of MalagaAndaluz Health ServiceCompletedChronic DisordersSpain